Clinical Trial Update: Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of intra-articular icatibant in patients with painful knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

Sponsor: Sanofi | Conditions: Joint Disease | Phase 2 | Status: COMPLETED